What's next for immunotherapy in locally advanced NSCLC?

Clin Adv Hematol Oncol. 2021 May;19(5):302-304.
No abstract available

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / therapy
  • Humans
  • Immunologic Factors
  • Immunotherapy* / trends
  • Lung Neoplasms* / therapy

Substances

  • Immunologic Factors